Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caricol is a botanical dietary supplement developed by Institut AllergoSan and distributed by Omni-Biotic US, designed to support digestive health and gastrointestinal function. It is formulated from concentrated organic papaya fruit using a patented preparation process based on Traditional Chinese Medicine and Ayurvedic principles, which reportedly enhances the activity of the enzyme papain by up to four times compared to standard papaya enzymes. Caricol is primarily indicated for the relief of occasional constipation, bloating, and indigestion by facilitating the enzymatic breakdown of dietary proteins and promoting overall gut balance. It is administered orally and is typically packaged in convenient stick-packs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Caricol.